Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$57.49M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
33.33%
Market Cap
$58.96M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.23M
Gross Margin
0.00%
TTM Avg
23.12%
3Y Avg
20.52%
5Y Avg
13.68%
Market Cap
$59.51M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$55.14M
Gross Margin
41.51%
TTM Avg
45.14%
3Y Avg
44.16%
5Y Avg
37.16%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.49M | 100.00% | 100.00% | 50.00% | 33.33% |
| OKYO Pharma Limited (OKYO)vs › | $56.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $56.10M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oncolytics Biotech Inc. (ONCY)vs › | $58.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $59.23M | 0.00% | 23.12% | 20.52% | 13.68% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $55.14M | 41.51% | 45.14% | 44.16% | 37.16% |
| Adicet Bio, Inc. (ACET)vs › | $60.30M | 0.00% | 0.00% | 25.00% | 50.00% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.81M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
